• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Eric A. Coleman, MD, MPH

Latest:

Use of Postacute Care After Discharge in Urban and Rural Hospitals

Rural patients receive less postacute care after hospital discharge than urban patients, especially after elective joint replacement-a condition selected for bundled payments.






Richard J. Scarfone, MD

Latest:

Pediatric Integrated Delivery System's Experience With Pandemic Influenza A (H1N1)

Experience of a pediatric integrated delivery system with the surge from the 2009 H1N1 pandemic is described, emphasizing scale, scope, and flexibility at multiple locations.


Mallika Kommareddi, MPH

Latest:

Adjusting Medicare Advantage Star Ratings for Socioeconomic Status and Disability

CMS implemented the Categorical Adjustment Index as part of the Medicare Advantage and Part D Star Rating Program in 2017. These analyses informed its development. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.


Craig Wakeford, MA

Latest:

Reconsidering the Economic Value of Multiple Sclerosis Therapies

Availability of multiple sclerosis (MS) therapies provides substantial value to the currently healthy (who may contract MS in the future), particularly when treatment is fully covered by insurance.




Karen Quigley, MPH

Latest:

A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare System

A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.



Harman Rahal

Latest:

Trends in Viral Hepatitis Cost-Effectiveness Studies

Regardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.


Kenneth M. Shermock, PharmD, PhD

Latest:

Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug Industries

A limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.


Ann Scheck McAlearney, ScD, MS

Latest:

Addressing Evolving Patient Concerns Around Telehealth in the COVID-19 Era

With a rapid shift to telehealth during the coronavirus disease 2019 (COVID-19) pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.






R. James Dudl, MD

Latest:

Preventing Myocardial Infarction and Stroke With a Simplified Bundle of Cardioprotective Medications

Bundled cardioprotective medications with simplified delivery reduced the risk of hospitalization for myocardial infarction or stroke among patients at high risk.


R. Adams Dudley, MD, MBA

Latest:

Small Practices' Experience With EHR, Quality Measurement, and Incentives

A study to assess clinician attitudes and experiences after participating in a New York City cardiovascular disease focused quality recognition and financial incentive program using health information technology.


Sarika Ogale, PhD

Latest:

Claims Identification of Patients With Severe Cancer-Related Symptoms

The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.



Pamela Gray Reger, LCSW

Latest:

Effectiveness of Care Coordination and Health Counseling in Advancing Illness

This prospective trial suggests that specialized care coordination and health counseling for patients coping with advanced stages of 4 life-limiting illnesses can be beneficial.




John F. McAna, PhD

Latest:

A Predictive Model of Hospitalization Risk Among Disabled Medicaid Enrollees

Predictive modeling can be used to identify disabled Medicaid beneficiaries at high risk of future hospitalizations who could benefit from appropriate interventions.


Mohanad AlMahmoud, MD

Latest:

The Association Between Insurance Type and Cost-Related Delay in Care: A Survey

In a survey of patients and visitors to a large academic medical center, middle-income respondents with private insurance reported more cost-related delays in care than those with public insurance.



Qian Shi, PhD, MPH

Latest:

Evaluation of the Quality Blue Primary Care Program on Health Outcomes

Implementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.